Work

Patient adherence and early biochemical outcomes following relugolix with stereotactic body radiation therapy (SBRT) for unfavorable prostate cancer.

Year: 2023

Type: conference-abstract

Source: JCO Oncology Practice

DOI: 10.1200/op.2023.19.11_suppl.526

Authors: Lindsey Gallagher, Jerry Xiao, Jessica Hsueh, Sarthak Shah, Malika Danner, Alan Zwart, Marilyn Ayoob, Thomas M. Yung, Tiffany Simpson, Mark Fallick, Deepak Kumar, Paul Denis Leger, Nancy Ann Dawson, Simeng Suy, Sean P. Collins

Institutions: Georgetown University Medical Center, Georgetown University, Myovant Sciences (United States), University of the District of Columbia, Georgetown Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4388203339

Cites:

Cited by:

Related to: 10